Table 2.
Risk factors for postbiopsy infection
| Variable | Univariate (P) | Multivariate (P) | OR | 95% CI of OR |
|---|---|---|---|---|
| Age | 0.084 | 0.162 | 0.051 | 0.970, 9.290 |
| Prostate size | 0.832 | 0.986 | 1.289 | 0.003, 9.923 |
| Serum PSA | 0.061 | 0.834 | 2.772 | 0.042, 6.984 |
| Histology | 0.247 | 0.335 | 2.634 | 0.368, 18.842 |
| LUTS | 0.623 | 0.995 | 2.754 | 0.345, 11.678 |
| Antibiotic group: Targeted versus empirical | 0.042 | 0.045 | 5.596 | 1.390, 38.108 |
| Comorbidity | 0.000 | 0.008 | 22.213 | 2.278, 216.612 |
CI=Confidence interval, OR=Odds ratio, PSA=Prostate-specific antigen, LUTS=Lower urinary tract symptoms, BPH=Benign prostatic hyperplasia